Rossari Biotech Statistics
Total Valuation
Rossari Biotech has a market cap or net worth of INR 47.22 billion. The enterprise value is 47.73 billion.
Market Cap | 47.22B |
Enterprise Value | 47.73B |
Important Dates
The next estimated earnings date is Friday, October 18, 2024.
Earnings Date | Oct 18, 2024 |
Ex-Dividend Date | Aug 16, 2024 |
Share Statistics
Rossari Biotech has 55.29 million shares outstanding. The number of shares has decreased by -0.01% in one year.
Shares Outstanding | 55.29M |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | +0.14% |
Owned by Insiders (%) | 62.62% |
Owned by Institutions (%) | 24.29% |
Float | 17.43M |
Valuation Ratios
The trailing PE ratio is 34.66 and the forward PE ratio is 27.78. Rossari Biotech's PEG ratio is 1.22.
PE Ratio | 34.66 |
Forward PE | 27.78 |
PS Ratio | 2.47 |
PB Ratio | 4.50 |
P/FCF Ratio | n/a |
PEG Ratio | 1.22 |
Enterprise Valuation
EV / Earnings | 35.00 |
EV / Sales | 2.50 |
EV / EBITDA | 18.67 |
EV / EBIT | 24.39 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.11 |
Debt / EBITDA | 0.47 |
Debt / FCF | n/a |
Interest Coverage | 11.66 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 11.32% |
Revenue Per Employee | 42.44M |
Profits Per Employee | 3.03M |
Employee Count | 450 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.28% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +4.28% |
50-Day Moving Average | 901.37 |
200-Day Moving Average | 790.61 |
Relative Strength Index (RSI) | 37.85 |
Average Volume (20 Days) | 126,624 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rossari Biotech had revenue of INR 19.10 billion and earned 1.36 billion in profits. Earnings per share was 24.64.
Revenue | 19.10B |
Gross Profit | 5.65B |
Operating Income | 1.95B |
Pretax Income | 1.85B |
Net Income | 1.36B |
EBITDA | 2.55B |
EBIT | 1.95B |
Earnings Per Share (EPS) | 24.64 |
Balance Sheet
The company has 677.94 million in cash and 1.19 billion in debt, giving a net cash position of -509.98 million or -9.22 per share.
Cash & Cash Equivalents | 677.94M |
Total Debt | 1.19B |
Net Cash | -509.98M |
Net Cash Per Share | -9.22 |
Equity (Book Value) | 10.48B |
Book Value Per Share | 189.70 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 29.57%, with operating and profit margins of 10.22% and 7.14%.
Gross Margin | 29.57% |
Operating Margin | 10.22% |
Pretax Margin | 9.70% |
Profit Margin | 7.14% |
EBITDA Margin | 13.36% |
EBIT Margin | 10.22% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.06%.
Dividend Per Share | 0.50 |
Dividend Yield | 0.06% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.01% |
Shareholder Yield | 0.07% |
Earnings Yield | 2.89% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |